Drug
Oxaliplatin clinical trials
Also written Eloxatin, RP 54780 and JM-83.
- studies test it
- 947
- open now
- 145
- in phase 3
- 151
- first study started
- 1998
Keep track of what changes. Save the Oxaliplatin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
943 studies that test it; most in 2004 (68); 1 more planned to start later
| Year | Studies |
|---|---|
| 1998 | 4 |
| 1999 | 18 |
| 2000 | 29 |
| 2001 | 8 |
| 2002 | 19 |
| 2003 | 39 |
| 2004 | 68 |
| 2005 | 58 |
| 2006 | 62 |
| 2007 | 46 |
| 2008 | 43 |
| 2009 | 36 |
| 2010 | 29 |
| 2011 | 48 |
| 2012 | 24 |
| 2013 | 27 |
| 2014 | 26 |
| 2015 | 32 |
| 2016 | 23 |
| 2017 | 29 |
| 2018 | 32 |
| 2019 | 33 |
| 2020 | 28 |
| 2021 | 28 |
| 2022 | 29 |
| 2023 | 30 |
| 2024 | 29 |
| 2025 | 40 |
| 2026 | 26 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 200
- Phase 2
- 655
- Phase 3
- 151
- Phase 4
- 13
- No phase
- 26
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 139 · Other 808
National Cancer Institute (NCI) (46) · Sanofi (35) · M.D. Anderson Cancer Center (22) · Sun Yat-sen University (21) · Hoffmann-La Roche (20) · Fudan University (17) · GERCOR - Multidisciplinary Oncology Cooperative Group (15) · UNICANCER (14)
Often tested with
Tested in the same studies.
Fluorouracil (271) · Capecitabine (260) · Leucovorin (176) · Gemcitabine (127) · Irinotecan (127) · Bevacizumab (99) · Docetaxel (84) · Tegafur (62)
Studies
Open first, then newest update. How each study uses Oxaliplatin is read from its arms, and is right about nine times in ten.
Testing it · 947
- Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II TrialRecruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT07847710Written as Gemcitabine & oxaliplatin
- Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System LymphomaNot yet recruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT07888621Written as Oxaliplatin
- A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT05139017Written as Oxaliplatin
- Bispecific Antibody-Based Holding/Bridging Therapy Before CAR-T in Aggressive B-Cell LymphomasRecruitingPhase 2National Research Center for Hematology, RussiaNCT07883135Written as Gemcitabine & oxaliplatin
- A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerRecruitingPhase 2AbbVieNCT06820463Written as Oxaliplatin
- A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)RecruitingPhase 1/2National Cancer Institute (NCI)NCT05849480Written as oxaliplatin
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesRecruitingPhase 1National Cancer Institute (NCI)NCT04847063Written as Oxaliplatin
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRecruitingPhase 2AstraZenecaNCT07069712Written as FLOT Chemotherapy
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingPhase 2National Cancer Institute (NCI)NCT05564377Written as Oxaliplatin
- Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHLRecruitingPhase 2Hoffmann-La RocheNCT06806033Written as Oxaliplatin
- A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesRecruitingPhase 2Mirati Therapeutics Inc.NCT07415031Written as Oxaliplatin
- A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)Not yet recruitingPhase 2Merck Sharp & Dohme LLCNCT07793942Written as Oxaliplatin
- NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerRecruitingPhase 1M.D. Anderson Cancer CenterNCT04615013Written as Oxaliplatin
- DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic CancerRecruitingPhase 1/2Ohio State University Comprehensive Cancer CenterNCT07705919Written as Oxaliplatin
- Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2Mayo ClinicNCT06078709Written as Oxaliplatin
- In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to LungRecruitingPhase 1University Health Network, TorontoNCT05611034Written as Oxaliplatin
- Pan Tumor Rollover StudyRecruitingPhase 2Bristol-Myers SquibbNCT03899155Written as Oxaliplatin
- NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar TrialRecruitingPhase 2Roswell Park Cancer InstituteNCT06821997Written as Oxaliplatin
- Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract CancerRecruitingPhase 2The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT07831993Written as Oxaliplatin
- A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract TumorsRecruitingPhase 4Zhai WenlongNCT07790445Written as Oxaliplatin + 5-Fluorouracil/Leucovorin
See all 947 studies that test Oxaliplatin →
Given in every arm · 609 — Oxaliplatin is usual care beside what is tested
- Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT04891289Written as Oxaliplatin
- HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric CancerRecruitingPhase 2Shanghai Changzheng HospitalNCT07621484Written as Oxaliplatin
- GLORY: Glofit-GemOx With Liso-Cel For LymphomaRecruitingPhase 2Massachusetts General HospitalNCT07711483Written as Gemcitabine & oxaliplatin
- A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric CancerRecruitingPhase 3Astellas Pharma Global Development, Inc.NCT07673887Written as Oxaliplatin
- A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingPhase 3Astellas Pharma Global Development, Inc.NCT06901531Written as Oxaliplatin
- CR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsRecruitingPhase 1/2Crescent Biopharma, Inc.NCT07335497Written as Oxaliplatin
- The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsRecruitingPhase 4PfizerNCT05203172Written as Oxaliplatin
- QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJRecruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT07716449Written as Oxaliplatin
- FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)Not yet recruitingPhase 2Sun Yat-sen UniversityNCT07621497Written as Oxaliplatin
- A Study of Neoadjuvant-adjuvant Durvalumab and FLOT Chemotherapy Followed by Adjuvant Durvalumab in Chinese Patients With Resectable GC/GEJC.Not yet recruitingPhase 3AstraZenecaNCT07877818Written as FLOT Chemotherapy
- Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06780111Written as Oxaliplatin
- A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United StatesRecruitingPhase 2BeOne MedicinesNCT07554521Written as Oxaliplatin
- A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal CarcinomaRecruitingPhase 1/2Nanjing Leads Biolabs Co.,LtdNCT07791758Written as Oxaliplatin injection
- A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C MutationNot yet recruitingPhase 2Eli Lilly and CompanyNCT07814417Written as Oxaliplatin
- Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJCNot yet recruitingPhase 2Fudan UniversityNCT07874425Written as Oxaliplatin
- ONO-4538 Phase II Rollover Study (ONO-4538-98)RecruitingPhase 2Ono Pharmaceutical Co., Ltd.NCT04566380Written as oxaliplatin
- A Study of ASP3082 in Adults With Advanced Solid TumorsRecruitingPhase 1Astellas Pharma IncNCT05382559Written as Oxaliplatin
- A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 3BeOne MedicinesNCT07043400Written as Oxaliplatin
- A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCCRecruitingPhase 2BeOne MedicinesNCT07733180Written as Oxaliplatin
- A Prospective, Single-center, Phase II Study of Neoadjuvant Serplulimab Plus XELOX and Bevacizumab in Locally Advanced Rectal CancerNot yet recruitingNot applicableTang-Du HospitalNCT07854964Written as Oxaliplatin
Showing 20 of 609.
As the comparator · 62 — what is tested is compared with Oxaliplatin
- A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerRecruitingPhase 3AstraZenecaNCT06764875Written as Oxaliplatin
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2RecruitingPhase 3AstraZenecaNCT07431281Written as Oxaliplatin
- Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06469944Written as Oxaliplatin
- A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerRecruitingPhase 1/2Janssen Research & Development, LLCNCT05379595Written as Oxaliplatin
- First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)RecruitingPhase 2Qilu Hospital of Shandong UniversityNCT06730373Written as Oxaliplatin
- Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.RecruitingPhase 3Gruppo Oncologico del Nord-OvestNCT06897644Written as Oxaliplatin
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerRecruitingPhase 3NRG OncologyNCT06958328Written as Oxaliplatin
- Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaRecruitingPhase 3BeBetter Med IncNCT06792253Written as Oxaliplatin Injection
- Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric CancerRecruitingPhase 2Sixth Affiliated Hospital, Sun Yat-sen UniversityNCT06510010Written as Oxaliplatin With S-1 (SOX)
- A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy FailureRecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07606599Written as Oxaliplatin
- A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)RecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07582315Written as Oxaliplatin
- Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingPhase 3Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.NCT07385703Written as Oxaliplatin Injection
- Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon CancerRecruitingPhase 3AkesoNCT07412613Written as Oxaliplatin
- Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCLNot yet recruitingNot applicableThe First Affiliated Hospital with Nanjing Medical UniversityNCT07389356Written as Rituximab+Gemcitabine+Oxaliplatin
- Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or MutationsNot yet recruitingPhase 3TransThera Sciences (Nanjing), Inc.NCT07328919Written as Oxaliplatin, fluorouracil, calcium folinate, irinotecan, capecitabine
- PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal CancerNot yet recruitingPhase 3Sun Yat-sen UniversityNCT07277842Written as CAPOX chemotherapy
- Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative PathologyNot yet recruitingPhase 4Liaoning Cancer Hospital & InstituteNCT07161453Written as SOX Chemotherapy
- Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical SurgeryNot yet recruitingPhase 4Liaoning Cancer Hospital & InstituteNCT07149181Written as SOX Chemotherapy
- Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric CancerNot yet recruitingPhase 4Liaoning Cancer Hospital & InstituteNCT07132528Written as SOX Chemotherapy
- Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverRecruitingPhase 3Federation Francophone de Cancerologie DigestiveNCT02885753Written as Oxaliplatin intravenous
Showing 20 of 62.
Codes
What other systems call Oxaliplatin · ClinicalTrials.gg INT006652
- MeSH (NLM) D000077150OxaliplatinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 04ZR38536JOXALIPLATINConfirmed FDA, NLM, Wikidata
- RxNorm 32592Confirmed FDA, Wikidata
- Wikidata Q422327oxaliplatinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1181OxaliplatinConfirmed FDA, Wikidata
- DrugBank DB00526One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077150 | Oxaliplatin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 04ZR38536J | OXALIPLATIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 32592 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422327 | oxaliplatin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1181 | Oxaliplatin | Confirmed FDA, Wikidata |
| DrugBank | DB00526 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.